Skip to main content

Table 1 Key patient characteristics

From: Comparison of global myocardial strain assessed by cardiovascular magnetic resonance tagging and feature tracking to infarct size at predicting remodelling following STEMI

Demographics
 Age, years 59.5 ± 11.0
 Male sex, n (%) 60 (92)
 Current/previous smoker, n (%) 28 (43.1)
 Hypercholesterolaemia, n (%) 15 (23.1)
 Hypertension, n (%) 19 (29.2)
 Admission HR, beats per minute 76 ± 12
 Admission Systolic BP, mmHg 124 ± 26
 Admission Diastolic BP, mmHg 75 ± 15
 Peak Creatine Kinase, iU/L 1064 (418–2588)
 Anterior STEMI, n (%) 30 (46)
Discharge Medications
 Aspirin, n (%) 57 (88)
 Clopidogrel, n (%) 59 (91)
 Warfarin, n (%) 6 (9)
 Statin, n (%) 63 (97)
 Beta-blocker, n (%) 64 (99)
 ACEi/ARA, n (%) 63 (97)
 Loop/Thiazide Diuretic, n (%) 5 (8)
 Spironolactone/Eplerenone, n (%) 7 (11)
CMR Parameters Baseline Follow-up p-value
 LVEDVI, ml/m−2 91.1 (84.5–102.2) 93.5 (85.0–106) 0.454
 LVESVI, ml/m−2 53.5 (47.6–65.9) 47.7 (39.8–61.6) 0.001
 LVEF, % 41.0 ± 8.40 47.2 ± 8.46 <0.001
 IS, % (of LV mass) 22.3 (14.5–35.5) 17.0 (12.3–22.8) <0.001
  1. Abbreviations: ACEi (Angiotensin Converting Enzyme Inhibitor), ARB (Angiotensin-II Receptor Blocker), BP (Blood Pressure), CAD (Coronary Artery Disease), HR (Heart Rate), IS (Infarct Size), LV (Left Ventricular), LVEDVI (Left Ventricular End Diastolic Volume), LVEF (Left Ventricular Ejection Fraction), LVESVI (Left Ventricular End Systolic Volume), N/A (Not Applicable), STEMI (ST-segment Elevation Myocardial Infarction)